Entheon Biomedical Corp
OTC:ENTBF
Cash Flow Statement
Cash Flow Statement
Entheon Biomedical Corp
| Jun-2020 | Sep-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(0)
|
(1)
|
(4)
|
(7)
|
(10)
|
(11)
|
(9)
|
(8)
|
(7)
|
(5)
|
(2)
|
(0)
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
3
|
3
|
4
|
4
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
1
|
1
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
-13%
|
(3)
-1 405%
|
(6)
-96%
|
(6)
-15%
|
(7)
-10%
|
(6)
+20%
|
(4)
+27%
|
(4)
+2%
|
(3)
+22%
|
(1)
+53%
|
(0)
+69%
|
0
N/A
|
0
-79%
|
(0)
N/A
|
(0)
+26%
|
(0)
-32%
|
(0)
+12%
|
(0)
-15%
|
(0)
-5%
|
(0)
-5%
|
(0)
+11%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
1
N/A
|
1
0%
|
1
N/A
|
1
-2%
|
(0)
N/A
|
(0)
-27%
|
(0)
+66%
|
(0)
+49%
|
1
N/A
|
1
+5%
|
1
-13%
|
1
+3%
|
0
-96%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
4
|
9
|
9
|
9
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
4
N/A
|
9
+112%
|
9
N/A
|
9
N/A
|
5
-47%
|
0
-99%
|
0
+1 580%
|
0
-94%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+339%
|
1
-23%
|
1
N/A
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
(0)
N/A
|
(0)
-13%
|
3
N/A
|
5
+84%
|
4
-17%
|
3
-16%
|
(1)
N/A
|
(4)
-469%
|
(4)
+13%
|
(3)
+14%
|
(1)
+73%
|
0
N/A
|
1
+188%
|
1
+23%
|
(0)
N/A
|
(0)
+28%
|
(0)
+26%
|
(0)
+15%
|
(0)
-36%
|
0
N/A
|
0
-60%
|
0
+39%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
-13%
|
(3)
-1 409%
|
(6)
-95%
|
(6)
-15%
|
(7)
-10%
|
(6)
+19%
|
(4)
+26%
|
(4)
+2%
|
(3)
+23%
|
(1)
+54%
|
(0)
+69%
|
0
N/A
|
0
-79%
|
(0)
N/A
|
(0)
+26%
|
(0)
-32%
|
(0)
+12%
|
(0)
-15%
|
(0)
-5%
|
(0)
-5%
|
(0)
+11%
|
|